TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$0.96
+0.09 (+10.79%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+3,874.7% upside
Low Target
$23.38
Average Target
$38.07
High Target
$43.34
Current Price
$0.96
Current
$0.96
$0.96
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Scenario Analysis
Bear Case
$23.38
2,341.0%
Low target
Base Case
$38.07
+3,874.7%
Avg target
Bull Case
$43.34
+4,425.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.69
-83.2% from high
52-Week Low
$0.77
+23.9% from low
Target vs 52W High
$38.07
+569.1% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-0.55
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals